... mycophenolate sodium is indicated for the prevention of kidney transplant rejection in adults. ... brand name CellCept. It was approved for use in the European ...

Mycophenolate Mofetil (CellCept) and Mycophenolate Sodium (Myfortic) are immunosuppressant drugs used in the treatment of several autoimmune diseases.

Myfortic® (mycophenolic acid) delayed-release tablets are an enteric formulation of mycophenolate sodium that delivers the active moiety mycophenolic acid (MPA) ...

CellCept® (mycophenolate mofetil) is a prescription medicine to prevent rejection (antirejection medicine) in people who have received a kidney, heart or liver ... Getting Brand-name CellCept · CellCept® (mycophenolate... · Patient Assistance

27 сент. 2022 г. · Mycophenolate sodium is used for prevention of organ rejection in transplant patients. Mycophenolate sodium is an immunosuppressant. It reduces ...

31 янв. 2024 г. · Side effects. Brand Name. US Brand Name. Cellcept. Myfortic. Myhibbin. Back to top. Description. Mycophenolate belongs to a group of medicines ...

Mycophenolate mofetil (brand name CellCept, Imulate, Ceptolate) and mycophenolate sodium (brand name Myfortic) are both converted in the body to mycophenolic ...

... of mycophenolate mofetil or mycophenolate sodium, when they are co-administered with cyclosporine ... COMMON BRAND NAME(S): Cellcept, Myhibbin. WARNING ...

0470 Medication name. Generic name: Mycophenolate sodium delayed-release tablet - oral. Pronunciation (MYE-koe-FEN-oh-late SOE-dee-um). Brand name(s) Myfortic.